Skip to main content
Premium Trial:

Request an Annual Quote

Or Just More Greens, Less Sugar

A Bay Area startup plans to provide a personalized diet and service that's based on an analysis of customers' genes, but Vox's Julia Belluz writes that she isn't convinced.

The company, Habit, is to begin offering its service next year, and, for $299, will analyze customers' blood and saliva samples at 60 biomarkers to see how they respond to certain foods. Through the company's app, customers can access data on how certain genes might be affecting their response to caffeine or lactose and what sort of diet the company's algorithm says is best suited to them. They can also consult with a dietitian through the app. Belluz adds that the company also plans to offer meal kits à la Blue Apron for an added, undisclosed fee.

But researchers tell Belluz that there's not much in the scientific literature that backs up such services, and she notes that the Academy of Nutrition and Dietetics advises against direct-to-consumer nutrigenomic services.

"From a scientific perspective, [personalized nutrition] is problematic," the University of Alberta's Tim Caulfield tells her. "For most human beings, this information isn't relevant. It's not going to benefit us any more than the basic health advice."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.